We are pleased to share information about the upcoming International Primary Immunodeficiencies Congress (IPIC 2025), which will take place in Prague, Czech Republic, from 5th to 7th November 2025.

IPIC 2025 brings together clinicians, researchers, patient organisation representatives, nurses, industry representatives, and other key stakeholders to advance clinical care and knowledge in primary immunodeficiencies (PIDs) and inborn errors of immunity (IEI).

This congress has established itself as a significant event in the PID clinical landscape, distinguished by its patient-centred approach and a CME-accredited programme.

Key topics to be addressed include:

  • AI tools to improve the clinical management of immunodeficiencies.
  • Advances in targeted therapies and gene therapies.
  • Complex case studies on persistent infections and regional clinical updates.
  • Management of hepatic manifestations and secondary immunodeficiencies.
  • Ethical and philosophical considerations in clinical genomics.
  • Transplantation challenges and successes.

Registration is now open. For more information about the programme and to register, please visit the official IPIC2025 website: https://ipic2025.com/